Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Kangmei Pharma to Raise $529 Million

publication date: Dec 29, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Kangmei Pharmaceutical will raise up to 3.5 billion RMB ($529 million) by offering rights for new shares to existing shareholders. The company will offer three new shares for each ten shares held at a price of 6.88 RMB each, a total of 508 million new shares. The company’s stock is currently selling for 20.99 RMB. More details....

Stock Symbol: (SHEX: 600518)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners